<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://the483.com/cbp-ieepa-tariff-refunds-walmart/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T03:10:50.000Z</news:publication_date>
      <news:title>Opened: CBP&apos;s $127B Tariff Refund Portal; Walmart Owed $10.2B</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/zaglin-drops-new-trial-motion/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T02:47:40.960Z</news:publication_date>
      <news:title>Zaglin Drops New Trial Motion, 8-Year FCPA Sentence Stands</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/trump-eo-psychedelic-compass-review/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-21T00:45:17.000Z</news:publication_date>
      <news:title>Trump EO Cuts Psychedelic Reviews, Compass Jumps 25%</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/lilly-kelonia-7b-igps-platform/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-20T23:19:52.000Z</news:publication_date>
      <news:title>Lilly Cuts $7B Deal for Kelonia and Its iGPS Platform</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/kelonia-lilly-venrock-45-fold/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-20T22:19:54.000Z</news:publication_date>
      <news:title>Kelonia Sale Hands Venrock a 45-Fold Return on $20M</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/trump-fda-fast-track-psychedelic-treatments/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-20T21:33:33.312Z</news:publication_date>
      <news:title>Trump Backs FDA Push to Fast-Track Psychedelic Treatments</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/astrazeneca-tozorakimab-third-phase3-win/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-20T17:27:18.000Z</news:publication_date>
      <news:title>Wins Third Phase 3 in COPD: AstraZeneca&apos;s Tozorakimab Eyes $5B Peak</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/lilly-kelonia-vivo-car-t-deal/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-20T16:31:25.000Z</news:publication_date>
      <news:title>Lilly Bets on Kelonia&apos;s In Vivo CAR-T</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://the483.com/novo-etavopivat-scd-fda-filing/</loc>
    <news:news>
      <news:publication>
        <news:name>The 483</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-04-20T13:51:19.530Z</news:publication_date>
      <news:title>Novo Targets FDA Filing for Etavopivat After 27% VOC Reduction</news:title>
    </news:news>
  </url>
</urlset>